Publication | Closed Access

Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial

VaccinationVaccine SafetyVaccine DevelopmentHealthy VolunteersImmunologyOral LiveInfection ControlPhase 2MedicineVaccine Research